DK1551850T3 - 2"-oxo-voruscharin og derivater deraf - Google Patents

2"-oxo-voruscharin og derivater deraf

Info

Publication number
DK1551850T3
DK1551850T3 DK03757941T DK03757941T DK1551850T3 DK 1551850 T3 DK1551850 T3 DK 1551850T3 DK 03757941 T DK03757941 T DK 03757941T DK 03757941 T DK03757941 T DK 03757941T DK 1551850 T3 DK1551850 T3 DK 1551850T3
Authority
DK
Denmark
Prior art keywords
voruscharin
oxo
derivatives
disclosed
compound
Prior art date
Application number
DK03757941T
Other languages
Danish (da)
English (en)
Inventor
Quaquebeke Eric Van
Jean-Claude Braekman
Gentiane Simon
Pierre Guissou
Odile Germaine Nacoulma
Janique Dewelle
Robert Kiss
Francis Darro
Original Assignee
Unibioscreen Sa
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20020447192 external-priority patent/EP1408043A1/de
Application filed by Unibioscreen Sa, Univ Bruxelles filed Critical Unibioscreen Sa
Application granted granted Critical
Publication of DK1551850T3 publication Critical patent/DK1551850T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
DK03757941T 2002-10-09 2003-10-09 2"-oxo-voruscharin og derivater deraf DK1551850T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20020447192 EP1408043A1 (de) 2002-10-09 2002-10-09 2" Oxo-Voruscharin und Analoge davon
US42006702P 2002-10-21 2002-10-21

Publications (1)

Publication Number Publication Date
DK1551850T3 true DK1551850T3 (da) 2006-09-25

Family

ID=32095057

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03757941T DK1551850T3 (da) 2002-10-09 2003-10-09 2"-oxo-voruscharin og derivater deraf

Country Status (13)

Country Link
US (1) US7320971B2 (de)
EP (1) EP1551850B1 (de)
JP (1) JP2006511483A (de)
AT (1) ATE327240T1 (de)
AU (1) AU2003273974B2 (de)
CA (1) CA2501774C (de)
DE (1) DE60305520T2 (de)
DK (1) DK1551850T3 (de)
ES (1) ES2265583T3 (de)
HK (1) HK1082727A1 (de)
MX (1) MXPA05003633A (de)
PT (1) PT1551850E (de)
WO (1) WO2004033465A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009004890A (es) * 2006-11-09 2009-05-21 Unibioscreen Sa Direccionamiento de subunidades alpha-1 o alpha-3 de na+, k+-atpasa en el tratamiento de enfermedades proliferativas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645988A (en) 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
GB9710698D0 (en) * 1997-05-24 1997-07-16 Verkaik Margaretha S E Composition

Also Published As

Publication number Publication date
DE60305520T2 (de) 2007-05-16
ES2265583T3 (es) 2007-02-16
MXPA05003633A (es) 2005-12-14
WO2004033465B1 (en) 2004-06-17
HK1082727A1 (en) 2006-06-16
PT1551850E (pt) 2006-10-31
WO2004033465A1 (en) 2004-04-22
CA2501774C (en) 2011-12-06
ATE327240T1 (de) 2006-06-15
US7320971B2 (en) 2008-01-22
US20060166952A1 (en) 2006-07-27
EP1551850A1 (de) 2005-07-13
EP1551850B1 (de) 2006-05-24
DE60305520D1 (de) 2006-06-29
AU2003273974A1 (en) 2004-05-04
CA2501774A1 (en) 2004-04-22
AU2003273974B2 (en) 2009-08-13
JP2006511483A (ja) 2006-04-06

Similar Documents

Publication Publication Date Title
NO2020031I1 (no) kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat
CY2015003I2 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
CY1108041T1 (el) Αναστολεις της rho-κινασης
ATE368031T1 (de) Neue gamma secretase inhibitoren
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
DE60312017D1 (de) Sulfonderivate zur hemmung von gamma-secretase
PL367682A1 (en) Dolastatin 10 derivatives
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
DE50310516D1 (de) Fredericamycin-derivate
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
BRPI0415355A (pt) triarilimidazóis
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf
WO2003080624A3 (en) Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
TW200503672A (en) 2-aminobenzoyl derivatives
ATE293107T1 (de) Luminacine analoge und deren verwendung
UA96742C2 (en) Mek inhibitors and use thereof